From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Acetaminophen Use Associated with Decreased Renal Function

In an observational study, renal toxicity was more pronounced in older women with estimated lifetime acetaminophen intakes of ≥3000 g.

Non-narcotic analgesics are thought to be associated with renal toxicity, but distinctions in risk among acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs are unclear. Researchers assessed the renal effects of these three analgesic classes in 1697 women (mean age, 57) who were participating in the Nurses' Health Study and who had provided blood samples in 1989 and in 2000.

Information on lifetime use of non-narcotic analgesics was collected retrospectively by questionnaire in 1999 and was used to estimate lifetime intake. Mean estimated glomerular filtration rate (GFR) declined from 88 to 79 mL/min/1.73 m2. In multivariate analysis, only acetaminophen was associated with a mean decline in GFR of at least 30%. Odds ratios for a 30% decline in GFR increased from 1.4 for women with estimated lifetime acetaminophen intakes of 100-499 g to 2.19 for women with estimated lifetime intakes of ≥3000 g (compared with odds for women who had estimated lifetime intakes of <100 g).

Comment: Although these results are limited by recall bias for both the amount and type of analgesics used, and by the use of estimated GFR, these factors should not have bolstered the reported association with acetaminophen only. Considering these data and other known risks of non-narcotic analgesic use, physicians should advise patients to use all such drugs parsimoniously.

— Thomas L. Schwenk, MD

Published in Journal Watch General Medicine August 3, 2004

Citation(s):

Curhan GC et al. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med 2004 Jul 26; 164:1519-24.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Related Content

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2004. Massachusetts Medical Society. All rights reserved.